Vivakor, INC. 8-K Filing
Ticker: VIVK · Form: 8-K · Filed: Dec 30, 2025 · CIK: 1450704
| Field | Detail |
|---|---|
| Company | Vivakor, INC. (VIVK) |
| Form Type | 8-K |
| Filed Date | Dec 30, 2025 |
| Pages | 3 |
| Reading Time | 3 min |
| Key Dollar Amounts | $5,117,647.06, $4,350,000, $2,419,766.75 |
| Sentiment | neutral |
Sentiment: neutral
FAQ
What type of filing is this?
This is a 8-K filing submitted by Vivakor, INC. (ticker: VIVK) to the SEC on Dec 30, 2025.
What are the key financial figures in this filing?
Key dollar amounts include: $5,117,647.06 (), in the aggregate principal amount of $5,117,647.06 in connection with a Securities Purchas); $4,350,000 (the Lender Notes, the Company received $4,350,000 prior to deducting customary fees. Bet); $2,419,766.75 (al of the Lenders converting a total of $2,419,766.75 of the amounts due under the Lender Not).
How long is this filing?
Vivakor, INC.'s 8-K filing is 3 pages with approximately 772 words. Estimated reading time is 3 minutes.
Where can I view the full 8-K filing?
The complete filing is available on SEC EDGAR. You can also read the AI-decoded analysis with risk assessment and key highlights on ReadTheFiling.
Filing Stats: 772 words · 3 min read · ~3 pages · Grade level 11.4 · Accepted 2025-12-30 17:23:24
Key Financial Figures
- $5,117,647.06 — ), in the aggregate principal amount of $5,117,647.06 in connection with a Securities Purchas
- $4,350,000 — the Lender Notes, the Company received $4,350,000 prior to deducting customary fees. Bet
- $2,419,766.75 — al of the Lenders converting a total of $2,419,766.75 of the amounts due under the Lender Not
Filing Documents
- vivakorinc_8k.htm (8-K) — 28KB
- vivakorinc_ex99-1.htm (EX-99.1) — 12KB
- 0001829126-25-010357.txt ( ) — 206KB
- vivk-20251223.xsd (EX-101.SCH) — 3KB
- vivk-20251223_lab.xml (EX-101.LAB) — 33KB
- vivk-20251223_pre.xml (EX-101.PRE) — 22KB
- vivakorinc_8k_htm.xml (XML) — 3KB
02
Item 3.02 Unregistered Sales of Equity Securities As previously reported, between June 6, 2025 and June 9, 2025, Vivakor, Inc. (the "Company") issued convertible promissory notes (the "Lender Notes"), to seven non-affiliated accredited investors (the "Lenders"), in the aggregate principal amount of $5,117,647.06 in connection with a Securities Purchase Agreement entered into by and between the Company and the Lenders (the "Lender SPA"). Under the terms of the Lender SPA and the Lender Notes, the Company received $4,350,000 prior to deducting customary fees. Between December 23, 2025 and December 30, 2025, the Company received Notices of Conversion from several of the Lenders converting a total of $2,419,766.75 of the amounts due under the Lender Notes into 159,931,717 shares of the Company's common stock (the "Lender Shares"). Pursuant to the terms of the Lender Notes and the Notices of Conversion, the Company issued the Lender Shares. The Lender Shares were issued without a Rule 144 restrictive legend pursuant to a legal opinion received by the Company and its transfer agent. The issuances of the foregoing securities were exempt from registration pursuant to Section 4(a)(2) of the Securities Act promulgated thereunder as the holder is an accredited investor and familiar with our operations.
01
Item 7.01 Regulation FD Disclosure. On December 30, 2025, Vivakor issued a press release announcing the reset of the payment date for the dividend of shares of Adapti, Inc. that the Company owns to April 30, 2026. The full text of the press release is attached to this Current Report on Form 8-K as Exhibit 99.1 and is incorporated herein by reference in this Item 7.01. The information contained in this Item 7.01 and in the accompanying Exhibit 99.1 are deemed to be "furnished" and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or incorporated by reference in any filing under the Exchange Act or the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing.
Financial Statements and Exhibits
Financial Statements and Exhibits. Exhibit No. Exhibit 99.1* Press Release of Vivakor, Inc. dated December 30, 2025* 104 Cover Page Interactive Data File (formatted as Inline XBRL document). * These exhibits are deemed to be "furnished" and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or incorporated by reference in any filing under the Exchange Act or the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing. 1
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. VIVAKOR, INC. Dated: December 30, 2025 By: /s/ James H. Ballengee Name: James H. Ballengee Title: Chairman, President & CEO 2